Matt Kaeberlein: RFK Jr and Joe Rogan’s Peptide Claims: Longevity Expert Reacts
Peer-Reviewed Research
Key Takeaways
- Be skeptical of peptide claims – Most peptides lack high-quality evidence for efficacy despite popular claims
- GLP-1 agonists are currently the only peptide class with strong safety and efficacy data
- Check FDA Category 2 list before considering peptide use – BPC-157, Epitalon, GHK-Cu and others are prohibited for compounding
- Demand clinical evidence before trying any peptide – Anecdotes and personal testimonials aren’t sufficient proof
Notable Quotes
“If you’re not able to show us the data, what you’re doing is operating on faith and stating it as fact, which is a pretty bad idea when we’re talking about putting potentially toxic bioactive agents into your body.”
Bottom Line
Only consider FDA-approved peptides like GLP-1 agonists, verify all claims with clinical evidence, and avoid illegal compounded peptides due to safety concerns.
Explore More
- Matt Kaeberlein’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network